Evidence map›Paper›PMID 31451912›Full record

ReviewJournal of neurology2021

Artificial intelligence as an emerging technology in the current care of neurological disorders.

Urvish K Patel, Arsalan Anwar, Sidra Saleem, Preeti Malik, Bakhtiar Rasul, Karan Patel, Robert Yao, Ashok Seshadri, Mohammed Yousufuddin, Kogulavadanan Arumaithurai

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Journal of neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06334796 (Phase 1 Trial of the Implementation of an Artificial Intelligence-powered Virtual Assistant for Emergency Triage in Neurology), which is not on this map. Cited by 74 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 4 pooled it
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06334796 early_phase1completednot on this mapstarted 2023, after this paper: background citation

Phase 1 Trial of the Implementation of an Artificial Intelligence-powered Virtual Assistant for Emergency Triage in Neurology

TypeinterventionalSponsorFundación para la Lucha contra las Enfermedades Neurológicas de la InfanciaRan2023 to 2024Enrolled10ConditionsStroke, Guillain-Barre Syndrome, Facial Palsy, MigraineArmsVirtual Assistant
3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 4 syntheses or guidelines pooled it, 190 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Review
  9. Neuroscientific therapies for subjective tinnitus.Journal of Zhejiang University. Science. B · 2026
    Review
  10. Observational
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Progressive multiple sclerosis: Evaluating current therapies and exploring future treatment strategies.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  17. Review
  18. Review
  19. AI and Neurology.Neurological research and practice · 2025
    Review
  20. Review

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Urvish K PatelDepartment of Neurology and Public Health, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY, 10029, USA. dr.urvish.patel@gmail.com.ORCID http://orcid.org/0000-0002-6702-298X
Arsalan AnwarDepartment of Neurology, UH Cleveland Medical Center, Cleveland, OH, USA.
Sidra SaleemDepartment of Neurology, University of Toledo, Toledo, OH, USA.
Preeti MalikDepartment of Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Bakhtiar RasulDepartment of Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Karan PatelDepartment of Neuroscience, Johns Hopkins University, Baltimore, MD, USA.
Robert YaoDepartment of Biomedical Informatics, Arizona State University and Mayo Clinic Arizona, Scottsdale, AZ, USA.
Ashok SeshadriDepartment of Psychiatry, Mayo Clinic Health System, Rochester, MN, USA.
Mohammed YousufuddinDepartment of Internal Medicine, Mayo Clinic Health System, Austin, MN, USA.
Kogulavadanan ArumaithuraiDepartment of Neurology, Mayo Clinic Health System, Austin, MN, USA.
Icahn School of Medicine at Mount Sinai · USMayo Clinic Health System · USJohns Hopkins University · USMayo Clinic in Arizona · USUniversity of Toledo · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundArtificial intelligence (AI) has influenced all aspects of human life and neurology is no exception to this growing trend. The aim of this paper is to guide medical practitioners on the relevant aspects of artificial intelligence, i.e., machine learning, and deep learning, to review the development of technological advancement equipped with AI, and to elucidate how machine learning can revolutionize the management of neurological diseases. This review focuses on unsupervised aspects of machine learning, and how these aspects could be applied to precision neurology to improve patient outcomes. We have mentioned various forms of available AI, prior research, outcomes, benefits and limitations of AI, effective accessibility and future of AI, keeping the current burden of neurological disorders in mind. DISCUSSION: The smart device system to monitor tremors and to recognize its phenotypes for better outcomes of deep brain stimulation, applications evaluating fine motor functions, AI integrated electroencephalogram learning to diagnose epilepsy and psychological non-epileptic seizure, predict outcome of seizure surgeries, recognize patterns of autonomic instability to prevent sudden unexpected death in epilepsy (SUDEP), identify the pattern of complex algorithm in neuroimaging classifying cognitive impairment, differentiating and classifying concussion phenotypes, smartwatches monitoring atrial fibrillation to prevent strokes, and prediction of prognosis in dementia are unique examples of experimental utilizations of AI in the field of neurology. Though there are obvious limitations of AI, the general consensus among several nationwide studies is that this new technology has the ability to improve the prognosis of neurological disorders and as a result should become a staple in the medical community.

conclusionAI not only helps to analyze medical data in disease prevention, diagnosis, patient monitoring, and development of new protocols, but can also assist clinicians in dealing with voluminous data in a more accurate and efficient manner.

Indexed as

Artificial IntelligenceStrokeAlgorithmsHumansMachine LearningTechnologyAlzheimer’s diseaseArtificial intelligenceConcussionDeep learningEpilepsyMachine learningMovement disordersNeurological disordersStrokeSUDEPTechnology

Identifiers

PMID31451912
OpenAlexW2970809650

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.